Vironix Health: Intelligent RPM for Early Detection of Chronic Illnesses

Sumanth Swaminathan, Co-Founder and CEO

The ability to preemptively detect life-threatening lung and heart illnesses such as Chronic Obstructive Pulmonary Disease (COPD), Asthma, Congestive Heart Failure, and, in recent times, COVID-19, is a highly sought-after boon for both patients and care providers. While early intervention on health downturns helps patients avert health crises and avoid expensive healthcare procedures, it also incentivizes hospitals and physicians by growing remote monitoring revenue, enhancing value-based care bonuses, and minimizing 30-day readmission rates. Moreover, the pandemic has aggravated the need for a remote monitoring solution more than ever to reduce the burden of staffing shortages and keep healthcare providers safe. Having amassed decades’ worth of experience in R&D, ML applications, and respiratory and cardiovascular patient care, Vironix’s team of dedicated physicians, scientists, and technologists have forged a solution to this pressing issue.

The organization's approach to tackling degenerative disease progression and viral spread combines evolvingdisease management principles with the latest ML models trained on global clinical characteristic data of both diagnosed and at-risk individuals. Vironix specializes in early detection and remote care of infectious and chronic lung/heart illnesses. As an AI-enabled remote monitoring solution provider, Vironix provides tools designed to interpret a patient’s health information in real-time and help them understand when it deviates from the normal (in the case of exacerbations or health deterioration events).

“Our solutions improve patient safety and quality of life with no cost to the patient and guaranteed revenue generation for the physician (we don’t get paid until caregivers get paid).
As such, our solution aligns the incentives of all major healthcare players while lowering healthcare costs and enhancing patient care,” says Sumanth Swaminathan, CEO & Co-Founder of the company. Vironix’s SaaS product is a standalone remote patient monitoring tool that provides physicians and patients with real-time data and decision support regarding biometric irregularities (oxygen saturation, blood pressure, and more), symptom escalations, and disease-specific health scores — bolstered with cutting-edge AI technology. This proves especially invaluable when patients are experiencing ambiguous symptoms associated with multiple conditions or even asymptomatic health degeneration (such as silent hypoxia due to Covid-19). In these circumstances, the patient and physician may remain unaware of the risk until it’s too late.

Vironix also works with nurses to ensure that patients comply with all regulations and are eligible for reimbursement from health insurance companies. The HIPAA-compliant software automates the generation of detailed symptom history, caregiver monitoring, and physiological data reports to safeguard physicians against audits when biling insurers. In essence, the remote monitoring solution includes the AI-software, the monitoring devices, and the managed care providers needed to maximize patient health benefit and lower healthcare costs. On the other hand, Vironix’s APIs deliver disease-specific intelligence for various customer applications. “We bring everything one needs for a successful integration, including self-reported questionnaires, vital sign interpretations, and patient record storage,” adds Swaminathan. The managed APIs are essentially cloud applications that allow institutions to deploy Vironix’s ML algorithms and data analytic solutions into a plethora of patient-facing hardware and software. Since these APIs leverage RESTful tech, they can integrate into existing applications seamlessly, allowing employers and biometric device makers to cost-effectively use the solution’s data interpretation and analytics capabilities for self-monitoring and preventative care. The hardware-agnostic nature of Vironix’s APIs helps institutions to retain their brand identity and mold the customer experience to their requirements and standards.
Instead of creating a generic solution for detecting anomalies in vital signs, Vironix’s software is designed to target specific pulmonary and cardiac issues that include COVID-19, asthma, COPD, influenza, and heart failure. Additionally, since the AI software aggregates and interprets vast amounts of physiological data and symptom history in real time, providers can receive high reimbursements from insurers. The algorithms and prediction models are clinically proven to reduce symptom severity and significantly improve medication adherence among patients.

Vironix aligns the incentives of patients, providers, and payers. Our products simultaneously 1) improve patient health, stability, and quality of life, 2) increase caregiver revenue, efficiency, and safety, and 3) lower preventable emergency care costs

“The objective of our products is to raise user health awareness and provide precision intelligence and decision support in order to stave off avoidable health crises,” says Swaminathan. Since the solution is powered by evolving machine learning and mathematicalmodels, it understands a patient’s ‘trending’ health and notifies patients and managed care staff when there is a clinically and/or statistically significant deviation from ‘normal’. For example, while a COPD patient may have an oxygen saturation level of 92 percent (an alarmingly low level for a healthy individual), the solution would understand that this state is not “abnormal” for the patient and would not continuously triage the patient to the hospital.

Understanding the need of the hour among patients and caregivers, the team of seasoned entrepreneurs and brilliant scientists at Vironix has engineered its solutions to create the most impact in diagnostics, triage, and remote patient care. Using Vironix’s solution suite to monitor and proactively intervene on health escalations allows patients to reduce healthcare utilization, lessen symptom severity, avoid hospital readmissions, and ensure their overall long-term health.